Robin Magnard
Overview
Explore the profile of Robin Magnard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilt M, Magnard R, Carnicella S, Vachez Y
Front Neural Circuits
. 2025 Feb;
19:1537449.
PMID: 39991498
No abstract available.
2.
Vachez Y, Bahout M, Magnard R, David P, Carcenac C, Wilt M, et al.
Eur J Neurosci
. 2025 Feb;
61(4):e70019.
PMID: 39962903
The link between subthalamic nucleus deep brain stimulation (STN-DBS) and apathy in patients with Parkinson's disease (PD) remains a controversial topic. The literature is mixed and the most supported explanation...
3.
Magnard R, Cheng Y, Zhou J, Province H, Thiriet N, Janak P, et al.
bioRxiv
. 2024 Oct;
PMID: 39463939
Mesolimbic dopamine (DA) neurons are central to sequence learning and habit formation. Yet, the mechanisms by which cue-induced DA neural activity drives goal-directed or habitual sequence execution remain unknown. We...
4.
Garr E, Cheng Y, Jeong H, Brooke S, Castell L, Bal A, et al.
Sci Adv
. 2024 May;
10(22):eadn4203.
PMID: 38809978
Learning causal relationships relies on understanding how often one event precedes another. To investigate how dopamine neuron activity and neurotransmitter release change when a retrospective relationship is degraded for a...
5.
Cheng Y, Magnard R, Langdon A, Lee D, Janak P
bioRxiv
. 2024 Apr;
PMID: 38585868
Lack of cognitive flexibility is a hallmark of substance use disorders and has been associated with drug-induced synaptic plasticity in the dorsomedial striatum (DMS). Yet the possible impact of altered...
6.
Magnard R, Fouyssac M, Vachez Y, Cheng Y, Dufourd T, Carcenac C, et al.
Transl Psychiatry
. 2024 Feb;
14(1):86.
PMID: 38336862
Impulse control disorders (ICDs), a wide spectrum of maladaptive behaviors which includes pathological gambling, hypersexuality and compulsive buying, have been recently suggested to be triggered or aggravated by treatments with...
7.
Vachez Y, Carcenac C, Magnard R, Kerkerian-Le Goff L, Salin P, Savasta M, et al.
Mov Disord
. 2020 Jun;
35(6):1084-1085.
PMID: 32562462
No abstract available.
8.
Vachez Y, Carcenac C, Magnard R, Kerkerian-Le Goff L, Salin P, Savasta M, et al.
Mov Disord
. 2020 Jan;
35(4):616-628.
PMID: 31930749
Background: Apathy is one of the most disabling neuropsychiatric symptoms in Parkinson's disease (PD) patients and has a higher prevalence in patients under subthalamic nucleus deep brain stimulation. Indeed, despite...
9.
Magnard R, Vachez Y, Carcenac C, Boulet S, Houeto J, Savasta M, et al.
Front Behav Neurosci
. 2019 Jan;
12:312.
PMID: 30618665
Impulse control disorders (ICDs) are frequent behavioral complications of dopaminergic (DA) replacement therapies (DRTs) in Parkinson's disease (PD). Impulsive choice, which refers to an inability to tolerate delays to reinforcement,...
10.
Houeto J, Magnard R, Dalley J, Belin D, Carnicella S
Front Psychiatry
. 2016 Jun;
7:91.
PMID: 27303314
Apathy and impulsivity are two major comorbid syndromes of Parkinson's disease (PD) that may represent two extremes of a behavioral spectrum modulated by dopamine-dependent processes. PD is characterized by a...